Telomir Pharmaceuticals (TELO) Institutional Ownership

During the previous two years, 21 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Geode Capital Management LLC ($1.71M), Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Bank of New York Mellon Corp ($295K), State Street Corp ($232K), Charles Schwab Investment Management Inc. ($191K), and JPMorgan Chase & Co. ($171K).Learn more on TELO's institutional investors.

Of the 20 institutional investors that purchased Telomir Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($347.32K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($90.15K), Suncoast Equity Management ($51.19K), HighTower Advisors LLC ($43K), JPMorgan Chase & Co. ($37.98K), and Charles Schwab Investment Management Inc. ($35.56K).

Institutional investors have bought a total of 908,727 shares in the last 24 months. This purchase volume represents approximately $4.26M in transactions.

The following institutional investors have sold Telomir Pharmaceuticals stock in the last 24 months: Goldman Sachs Group Inc. ($18.25K).

Institutional investors have sold a total of 18,248 shares in the last 24 months. This volume of shares sold represents approximately $58.94K in transactions.